Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Adenomatous Polyposis Coli 2Adenoma 2Polyps 1Neoplastic Syndromes, Hereditary 1Intestinal Neoplasms 1Intestinal Diseases 1Genetic Diseases, Inborn 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Duodenal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Adenomatous Polyps 1

Interventions

Ursodeoxycholic Acid 2Endoscopy 1Eicosapentaenoic Acid 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Adenomatous Polyposis Coli × Ursodeoxycholic Acid × Clear all
NCT00808743 2013-05-16

PreDuoFAP

Radboud University Medical Center

Phase 2/3 Completed
37 enrolled
Gastrointestinal

Adenoma, Digestive System Diseases, Digestive System Neoplasms, Duodenal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplastic Syndromes, Hereditary, Adenomatous Polyposis Coli, Polyps, Adenomatous Polyps, Genetic Diseases, Inborn

NCT00134758 2009-07-29

Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients

Assistance Publique - Hôpitaux de Paris

Phase 2/3 Unknown
90 enrolled
Gastrointestinal

Adenoma, Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡